Global Micro-Invasive Glaucoma Surgery (MIGS) Devices In-depth analysis and Growth of Market
"Global
Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By
Surgery, By End User, By Region, By Country): Opportunities and
Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal
Space), By Surgery (Glaucoma - Cataract, Standalone), By End User
(HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country
(U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia,
Brazil, South Africa)"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
.
.
Description-
'
'
--
A comprehensive research report created through extensive primary
research (inputs from industry experts, companies, stakeholders) and
secondary research, the report aims to present the analysis of Global
Micro-Invasive Glaucoma Surgery Market on the basis of Target
(Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma in
conjunction with Cataract and Stand Alone Glaucoma), By End User
(Hospital Outpatient Departments - HOPDs and Ambulatory Surgery
Centers - ASCs), By Region (North America, Europe, APAC and ROW) and
By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea,
Australia, Brazil and South Africa).
Get
Sample
Report
With TOC @
https://www.researchmoz.us/enquiry.php?type=S&repid=1107693
'
'
--
Over the recent years, the global Micro-Invasive Glaucoma Surgery
industry has been growing rapidly as the global sales of iStent
device by Glaukos which was the only commercially available device in
United States has witnessed rapid growth post its FDA approval in
2012. Globally, the growth in micro-invasive glaucoma surgery device
market is driven by several MIGS devices entering the market in next
five years, rising number of glaucoma patients and rapidly aging
population.
--
According to Azoth Analytics research
report, “Global Micro-Invasive Glaucoma Surgery (MIGS) Devices
Market (By Target, By Surgery, By End User, By Region, By Country):
Opportunities and Forecast (2017-2022) - By Target (Trabecular
Meshwork, Suprachoroidal Space), By Surgery (Glaucoma – Cataract,
Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe,
APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, Japan,
South Korea, Australia, Brazil, South Africa)”, global market is
projected to display a robust growth represented by a CAGR of 47.10%
during 2017 – 2022, chiefly driven by several MIGS devices entering
the market in next five years, rising number of glaucoma patients and
rapidly aging population, high safety profile and reduced dependency
on prescription eye drops.
--
Among the targets, Trabecular Meshwork
currently dominates the Micro-Invasive Glaucoma Surgery market. Among
the surgeries, Stand Alone Glaucoma surgery is projected to witness
fastest growth. In terms of End User, Ambulatory Surgery Centers is
predicted to grow at a higher rate than HOPDs (Hospital Outpatient
Departments). Among the regions, Asia Pacific is predicted to advance
at the highest rate, mainly driven by large glaucoma population and
expansion of MIGS device in the region.
--
The report titled, “Global
Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By
Surgery, By End User, By Region, By Country): Opportunities and
Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal
Space), By Surgery (Glaucoma – Cataract, Standalone), By End User
(HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country
(U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia,
Brazil, South Africa)”, has covered and analyzed the potential of
Global Micro-Invasive Glaucoma Surgery Market and provides statistics
and information on market size, shares and growth factors. The report
intends to provide cutting-edge market intelligence and help decision
makers take sound investment evaluation. Besides, the report also
identifies and analyses the emerging trends along with major drivers,
challenges and opportunities in the global food service equipment
market. Additionally, the report also highlights market entry
strategies for various companies across the globe.
-- -- Scope of the Report-- --
--
Global Market (Actual Period: 2013-2016,
Forecast Period: 2017-2022)
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Target (Trabecular Meshwork, Suprachoroidal Space, Others)
• Global MIGS Device Market, By Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma)
• Global MIGS Device Market, By End User (Hospital Outpatient Departments, Ambulatory Surgery Centers)
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Target (Trabecular Meshwork, Suprachoroidal Space, Others)
• Global MIGS Device Market, By Surgery (Glaucoma in Conjunction with Cataract, Stand Alone Glaucoma)
• Global MIGS Device Market, By End User (Hospital Outpatient Departments, Ambulatory Surgery Centers)
--
Regional Markets – N. America, Europe,
APAC, ROW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Target
• Global MIGS Device Market, By Surgery
• Global MIGS Device Market, By End User
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Target
• Global MIGS Device Market, By Surgery
• Global MIGS Device Market, By End User
--
Country Analysis - US, Canada, UK,
Germany, France, Japan, South Korea, Australia, Brazil, South Africa
(Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Surgery in Percentage (2016, 2022)
• Global MIGS Device Market, By End User in Percentage (2016, 2022)
• Micro-Invasive Glaucoma Surgery Market
• Global MIGS Device Market, By Surgery in Percentage (2016, 2022)
• Global MIGS Device Market, By End User in Percentage (2016, 2022)
--
Other Report Highlights
• Market Dynamics – Trends, Drivers, Challenges
• Policy and Regulation
• Company Analysis – Glaukos, Alcon, Santen, Ivantis, Allergan
• Market Dynamics – Trends, Drivers, Challenges
• Policy and Regulation
• Company Analysis – Glaukos, Alcon, Santen, Ivantis, Allergan
--
Customization of the Report
The report could be customized according to the
client’s specific research requirements. No additional cost will be
required to pay for limited additional research.
.
.
Report
Enquiry and Other Query @
https://www.researchmoz.us/enquiry.php?type=E&repid=1107693
Comments
Post a Comment